Compound information
- Natural Products
- ZC253515
- Molecular Formula
- C27H40N6O8
- Molecular Weight
- 576.29076224 g/mol
- Structure
-
- IUPAC Name
- (2R)-2-[[(2R)-1-[(2S)-4-benzyloxy-2-(tert-butoxycarbonylamino)-4-oxo-butanoyl]pyrrolidine-2-carbonyl]amino]-5-guanidino-pentanoic acid
- InChI
- InChI=1S/C27H40N6O8/c1-27(2,3)41-26(39)32-19(15-21(34)40-16-17-9-5-4-6-10-17)23(36)33-14-8-12-20(33)22(35)31-18(24(37)38)11-7-13-30-25(28)29/h4-6,9-10,18-20H,7-8,11-16H2,1-3H3,(H,31,35)(H,32,39)(H,37,38)(H4,28,29,30)/t18-,19+,20-/m1/s1
- InChI Key
- MMUZQFYGDNUZHS-HSALFYBXSA-N
- SMILES
- CC(C)(C)OC(=O)N[C@@H](CC(=O)OCc1ccccc1)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCNC(=N)N)C(=O)O
- Source
- ZINC000106588181
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 41 | Ring Count | 2 |
Heteroatom Count | 14 | Rotatable Bond Count | 13 |
Hydrogen Bond Acceptor Count | 8 | Hydrogen Bond Donor Count | 6 |
Topological Polar Surface Area | 213.24 Å2 | LogP | 0.788 |
LogS | -2.686 | LogD | 0.592 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.002 | Pgp substrate | 0.987 |
HIA | 0.002 | F20 % | 0.747 |
F30 % | 0.026 | Caco-2 | -6.801 |
MDCK | -5.992 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.085 | PPB | 42.288 |
VD | 0.315 | Fu | 0.295 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.0 | CYP1A2 substrate | 0.341 |
CYP2A6 substrate | 0.241 | CYP2B6 substrate | 0.358 |
CYP2C19 inhibitor | 0.029 | CYP2C19 substrate | 0.542 |
CYP2C8 substrate | 0.237 | CYP2C9 inhibitor | 0.043 |
CYP2C9 substrate | 0.784 | CYP2D6 inhibitor | 0.034 |
CYP2D6 substrate | 0.174 | CYP2E1 substrate | 0.277 |
CYP3A4 inhibitor | 0.004 | CYP3A4 substrate | 0.945 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.886 | CL | 4.46 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.194 | Hepatotoxicity | 0.092 |
Mutagenicity | 0.177 | Rat Oral Acute Toxicity | 0.03 |
FDAMDD | 0.336 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.0 | Eye Corrosion | 0.003 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.065 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -2.288 | IGC50 | 2.028 |
LC50FM | 0.026 | LC50DM | 1.473 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.487 | NR-AR-LBD | 0.435 |
NR-AhR | 0.005 | NR-Aromatase | 0.016 |
NR-ER | 0.513 | NR-ER-LBD | 0.388 |
NR-PPAR-gamma | 0.341 | SR-ARE | 0.313 |
SR-ATAD5 | 0.336 | SR-HSE | 0.043 |
SR-MMP | 0.009 | SR-p53 | 0.057 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.